Experts present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.

Overview
In an evolving healthcare environment with constant economic pressures, there is an increasing need to generate robust and actionable payer insights, beginning in the early stages of development and continuing all the way to post-launch. Actionable payer insights facilitate an informed approach to evidence generation that will be meaningful to payer, HTA, and medical decision-makers.

This webinar is designed to inform HEOR, RWE, and market access leads in pharmaceutical, biotech, and medical device companies.

Full Description
In an evolving healthcare environment with constant economic pressures, clinical innovation alone is not sufficient to achieve optimal reimbursement and patient access.

Payers, regulators, and health technology assessment (HTA) agencies prioritize products that demonstrate the most compelling clinical benefit versus risk, as well as economic value, and increasingly are prioritizing benefits to patients.

Strategically timed payer insights can inform a relevant and timely evidence package and drug development strategy by defining the data required to support an optimal place in therapy/treatment pathways and by describing the value of the product in populations of unmet need. Understanding the evolving competitive and HTA landscape facilitates a forward-thinking approach to evidence strategies across the product lifecycle and increases the likelihood of optimal access.

In such a dynamic healthcare environment, the utilization of agile platforms and fit-for-purpose engagement models can drive an efficient and iterative approach to payer insights, evidence-synthesis, and evidence-generation. These approaches allow for flexibility and agility, and ensure that the process can be accelerated without compromising scientific rigor, facilitating the generation of evidence packages that are relevant and important for decision-makers.

Key Topics Include:

  • Understand why generating payer insights and relevant, impactful evidence in a timely manner is ‘business critical’.
  • Increase awareness of available agile platforms and fit-for-purpose engagement models that drive an iterative approach to payer insights, evidence-synthesis, and evidence-generation.
  • Understand the business impact of utilizing these solutions using case studies.
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.

Presenters

Vice President
Evidence Strategy
Genesis Research

With over two decades in the pharma industry, Priti Jhingran has focused on understanding evidence needs and delivering tools/solutions for access decision makers/HTAs. She has led multiple enterprise level initiatives; launched 15+ products; and developed diverse teams of scientists dedicated to the generation, dissemination, and communication of evidence.

Director
Operations Team
Market Access Transformation

Tijana Ignjatovic has over 15-years of consultancy experience within market access, having conducted over 100 pieces of research across a range of therapy areas during her time at MAT. This experience has given Tijana in-depth knowledge on how to optimize research methodologies to meet the strategic intent of payer research and provide actionable recommendations.

Production Partner

Genesis Research

Genesis Research is an international research organization that provides scientifically rigorous, tech-enabled evidence-based solutions to pharmaceutical, biotech, and medical device companies.

Additional Content From HealthEconomics.Com

Social Media Data: Opportunities and Insights for Clinical Research

Social Media Data: Opportunities and Insights for Clinical Research

Hear four experts from ICON and Kap Code provide insights on how to collect, use, analyze, and interpret social media data in different contexts. These experts share knowledge from over fifteen years of successfully developing and adapting algorithms to treat this kind of data.

Related Content